文献速递传染病防控与疫情报告免疫规划

2016年2月至6月法国博若莱地区B群侵袭性脑膜炎球菌病社区暴发:从预警到针对性疫苗接种

Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination.
PubMed 文献 · Euro Surveill · 2018-01-01

2016年2月至3月,法国里昂北部小区域3周内发生4例B群侵袭性脑膜炎球菌病,无死亡但2例有后遗症,由ST-32克隆复合体罕见菌株引起,该地区发病率22.5/10万超过流行阈值10/10万,0-24岁标准化发病比96。决定对2月龄至24岁人群接种4CMenB/Bexsero疫苗,2016年4月至9月接种运动,一剂覆盖率47%、两剂40%。

要点

  • 2016年2-3月法国博若莱地区3周内发生4例B群侵袭性脑膜炎球菌病,无死亡但2例有后遗症。
  • 该地区B群侵袭性脑膜炎球菌病发病率为22.5/10万,超过流行阈值10/10万;0-24岁标准化发病比为96。
  • 对2月龄至24岁人群接种4CMenB/Bexsero疫苗,一剂覆盖率47%、两剂覆盖率40%。

核心结论

  • 本次社区暴发由ST-32克隆复合体罕见脑膜炎球菌菌株引起,该菌株可被4CMenB/Bexsero疫苗覆盖。
  • 观察到的病例数在0-24岁年龄组显著高于预期(标准化发病比96),提示该侵袭性菌株可能在该亚人群中显现。

研究设计与样本

  • 2016年2月和3月,法国奥弗涅-罗讷-阿尔卑斯大区里昂北部一个小区域3周内发生4例B群侵袭性脑膜炎球菌病。
  • 根据法国建议,决定对在流行区居住、工作或学习的2月龄至24岁人群接种疫苗;接种运动于2016年4月至9月开展。

主要发现

  • 4例病例中无死亡,但2例有后遗症。
  • 该地区B群侵袭性脑膜炎球菌病发病率为22.5/10万居民,超过流行阈值(10/10万)。
  • 0-24岁年龄组观察到的病例数显著高于预期(标准化发病比:96)。
  • 疫苗接种覆盖率估计为一剂47%、两剂40%;最低覆盖率估计见于3岁以下和15-19岁年龄组。
  • 加强流行病学和微生物学监测于2016年6月在流行区外报告了第5例病例。

关键数值与推荐

  • 该地区B群侵袭性脑膜炎球菌病发病率22.5/10万居民,高于流行阈值10/10万。
  • 0-24岁年龄组标准化发病比为96。
  • 疫苗接种覆盖率:一剂47%,两剂40%。

临床怎么用

  • 根据法国建议,对在流行区居住、工作或学习的2月龄至24岁人群接种4CMenB/Bexsero疫苗。
  • 疫苗接种运动于2016年4月至9月开展。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In February and March 2016, four cases of serogroup B invasive meningococcal disease (IMD) occurred over 3 weeks in a small area north of Lyon in the Auvergne-Rhône-Alpes region, France. There were no deaths but two cases had sequelae. This community outbreak was caused by a rare meningococcal strain of the clonal complex ST-32, covered by the 4CMenB/Bexsero vaccine. The incidence rate for serogroup B IMD in this area was 22.5 per 100,000 inhabitants, which is above the epidemic threshold (10/100,000). The number of cases observed was significantly higher than expected in the age group of 0-24 year-olds (standardised incidence ratio: 96). These results suggested the potential emergence of this invasive strain in this sub-population. In accordance with French recommendations, it was decided to vaccinate the population aged between 2 months and 24 years, living, working or studying in the epidemic area. The vaccination campaign took place from April to September 2016. Vaccination coverage was estimated at 47% for one dose and 40% for two doses. The lowest coverage estimations were observed for the age groups younger than 3 and 15-19 years. Enhanced epidemiological and microbiological surveillance reported a fifth case in June 2016, outside the epidemic area.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Thabuis A, Tararbit K, Taha MK, et al. Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination. Euro Surveill. 2018. PMID: 30017022. doi:10.2807/1560-7917.ES.2018.23.28.1700590

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。